[go: up one dir, main page]

ATE430734T1 - Isochinoline und deren herstellung - Google Patents

Isochinoline und deren herstellung

Info

Publication number
ATE430734T1
ATE430734T1 AT03020565T AT03020565T ATE430734T1 AT E430734 T1 ATE430734 T1 AT E430734T1 AT 03020565 T AT03020565 T AT 03020565T AT 03020565 T AT03020565 T AT 03020565T AT E430734 T1 ATE430734 T1 AT E430734T1
Authority
AT
Austria
Prior art keywords
isochinolines
production
Prior art date
Application number
AT03020565T
Other languages
English (en)
Inventor
John-Joseph Savarese
Roy-Archibald Swaringen
Vincente Samano
Original Assignee
Avera Pharmaceuticals Inc
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706117.0A external-priority patent/GB9706117D0/en
Priority claimed from GBGB9724987.4A external-priority patent/GB9724987D0/en
Application filed by Avera Pharmaceuticals Inc, Cornell Res Foundation Inc filed Critical Avera Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE430734T1 publication Critical patent/ATE430734T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03020565T 1997-03-25 1998-03-23 Isochinoline und deren herstellung ATE430734T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9706117.0A GB9706117D0 (en) 1997-03-25 1997-03-25 Ultra-short acting neuromuscular blockers
GBGB9724987.4A GB9724987D0 (en) 1997-11-27 1997-11-27 Ultra-short acting neuromuscular blockers

Publications (1)

Publication Number Publication Date
ATE430734T1 true ATE430734T1 (de) 2009-05-15

Family

ID=26311255

Family Applications (3)

Application Number Title Priority Date Filing Date
AT98922626T ATE254107T1 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
AT03020565T ATE430734T1 (de) 1997-03-25 1998-03-23 Isochinoline und deren herstellung
AT98912494T ATE295351T1 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98922626T ATE254107T1 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98912494T ATE295351T1 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Country Status (37)

Country Link
US (2) US6187789B1 (de)
EP (4) EP0971898B1 (de)
JP (3) JP4112016B2 (de)
KR (2) KR100554601B1 (de)
CN (1) CN1203061C (de)
AP (1) AP1797A (de)
AR (1) AR012156A1 (de)
AT (3) ATE254107T1 (de)
AU (2) AU745382B2 (de)
BR (1) BR9808422B1 (de)
CA (1) CA2284802C (de)
CO (1) CO4940499A1 (de)
CZ (1) CZ293786B6 (de)
DE (3) DE69840816D1 (de)
DK (2) DK0971898T3 (de)
EA (1) EA002224B1 (de)
EE (1) EE04113B1 (de)
ES (2) ES2242275T3 (de)
HK (1) HK1023342A1 (de)
HR (1) HRP980157B1 (de)
HU (1) HU228230B1 (de)
ID (1) ID22901A (de)
IL (1) IL131918A (de)
IS (2) IS2346B (de)
MA (1) MA26476A1 (de)
MY (1) MY121316A (de)
NO (1) NO314726B1 (de)
NZ (1) NZ337797A (de)
PE (1) PE68399A1 (de)
PL (1) PL190860B1 (de)
PT (2) PT971898E (de)
RS (1) RS49869B (de)
SI (1) SI0975599T1 (de)
TR (1) TR199902330T2 (de)
TW (1) TW505635B (de)
UY (1) UY24933A1 (de)
WO (2) WO1998042674A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0971898B1 (de) * 1997-03-25 2005-05-11 Avera Pharmaceuticals, Inc. Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
US6844904B2 (en) * 2002-12-07 2005-01-18 Cubic Corporation Fast PDLC device
US20050192243A1 (en) * 2003-10-28 2005-09-01 Savarese John J. Neuromuscular blocking agents and antagonists thereof
JP5213137B2 (ja) 2006-12-06 2013-06-19 コーネル リサーチ ファウンデーション, インコーポレイテッド 中程度の持続時間の神経筋遮断剤およびそのアンタゴニスト
BRPI0808272A2 (pt) * 2007-03-08 2014-07-08 Chemagis Ltd "método para cromatograficamente separar o isômero 1r-cis, 1´r-cis de uma mistura de isômeros de (1r-1'r) - atracúrio, besilato de cisatracúrio e isômero 1r-cis, 1'r-cis do besilato de cisatracúrio"
US20100087650A1 (en) * 2007-03-26 2010-04-08 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
WO2009007946A1 (en) * 2007-07-09 2009-01-15 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
AU2008243747B2 (en) 2007-05-01 2013-03-07 Chemagis Ltd. Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
CA2685491A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
BRPI0811687A2 (pt) 2007-06-18 2015-02-18 Chemagis Ltd MÉTODO PARA SEPARAR O ISÔMETRO 1R-CIS, 1'R-CIS (cisatracúrio) DE UMA MISTURA DE ISÔMEROS DE SAIS DE (1R, 1'R) - ATRACÚRIO
AU2008320380A1 (en) * 2007-10-29 2009-05-07 Chemagis Ltd. Novel R,R'-atracurium salts
AU2009241211A1 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
CN102573794B (zh) 2009-08-19 2017-03-15 康奈尔大学 供生理注射用的半胱氨酸
ES2625329T3 (es) * 2012-06-29 2017-07-19 Cornell University Agentes bloqueantes neuromusculares asimétricos reversibles de duración ultra-corta, corta o intermedia
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
WO2014210369A2 (en) * 2013-06-28 2014-12-31 Cornell University Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents
CN108375644B (zh) * 2016-12-07 2021-11-30 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN110776481B (zh) * 2018-07-24 2023-06-16 四川大学华西医院 一类双阳离子化合物及其制备方法和用途
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN111662230A (zh) * 2019-03-06 2020-09-15 四川道珍科技有限公司 一类苄基异喹啉化合物、制备方法和用途
CN110117297A (zh) * 2019-04-10 2019-08-13 珠海市赛纬电子材料股份有限公司 一种2-磷酸盐基硫酸丙烯酯的制备方法
WO2021115413A1 (zh) * 2019-12-11 2021-06-17 江苏恒瑞医药股份有限公司 神经肌肉阻滞剂及其制备方法
CN111471013B (zh) * 2020-05-26 2021-04-30 朗天药业(湖北)有限公司 一种米库氯铵及其注射液的制备方法
CN111909089B (zh) * 2020-08-14 2023-04-14 广东嘉博制药有限公司 一种米库氯铵对照品的制备方法
CN114057642B (zh) * 2021-12-10 2023-03-28 广东嘉博制药有限公司 一种米库氯铵中间体的合成方法
CN115073373A (zh) * 2022-07-08 2022-09-20 广东嘉博制药有限公司 一种不对称合成(r)-5’-甲氧基劳丹素的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
ES472229A1 (es) * 1977-08-01 1979-03-16 Massachusetts Gen Hospital Un metodo de preparar un compuesto
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
BG41897A1 (en) 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
GB9015473D0 (en) * 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
JPH04112016A (ja) * 1990-09-03 1992-04-14 Fuji Electric Co Ltd トランスファ成形金型用プランジャ及びトランスファ成形装置
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
EP0971898B1 (de) * 1997-03-25 2005-05-11 Avera Pharmaceuticals, Inc. Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Also Published As

Publication number Publication date
CN1257483A (zh) 2000-06-21
SI0975599T1 (en) 2004-04-30
NZ337797A (en) 2001-03-30
IS5185A (is) 1999-09-17
ES2242275T3 (es) 2005-11-01
CA2284802A1 (en) 1998-10-01
IL131918A0 (en) 2001-03-19
CO4940499A1 (es) 2000-07-24
IL131918A (en) 2005-09-25
EP0975599B1 (de) 2003-11-12
MY121316A (en) 2006-01-28
MA26476A1 (fr) 2004-12-20
CN1203061C (zh) 2005-05-25
JP4112016B2 (ja) 2008-07-02
TR199902330T2 (xx) 2000-02-21
EE04113B1 (et) 2003-08-15
HRP980157A2 (en) 1999-02-28
HUP0001556A2 (hu) 2001-04-28
EP0975599A1 (de) 2000-02-02
PL190860B1 (pl) 2006-02-28
DE69840816D1 (de) 2009-06-18
AU6730598A (en) 1998-10-20
EP1380573A3 (de) 2004-01-21
AU7521098A (en) 1998-10-20
RS49869B (sr) 2008-08-07
CA2284802C (en) 2009-06-16
EA199900756A1 (ru) 2000-08-28
DE69819703T2 (de) 2004-09-30
EP1526130A1 (de) 2005-04-27
PE68399A1 (es) 1999-07-23
DE69819703D1 (de) 2003-12-18
ES2210757T3 (es) 2004-07-01
AR012156A1 (es) 2000-09-27
US6177445B1 (en) 2001-01-23
HK1023342A1 (en) 2000-09-08
HU228230B1 (en) 2013-02-28
UY24933A1 (es) 2000-12-29
CZ293786B6 (cs) 2004-07-14
ATE295351T1 (de) 2005-05-15
PT971898E (pt) 2005-07-29
WO1998042674A1 (en) 1998-10-01
AP9901658A0 (en) 1999-09-30
BR9808422B1 (pt) 2010-08-24
CZ340499A3 (cs) 2000-04-12
JP2002503220A (ja) 2002-01-29
ATE254107T1 (de) 2003-11-15
NO994680L (no) 1999-11-24
DE69830157D1 (de) 2005-06-16
NO314726B1 (no) 2003-05-12
NO994680D0 (no) 1999-09-24
EE9900424A (et) 2000-04-17
EP1380573A2 (de) 2004-01-14
EP0971898A1 (de) 2000-01-19
US6187789B1 (en) 2001-02-13
JP4112015B2 (ja) 2008-07-02
PT975599E (pt) 2004-03-31
AP1797A (en) 2007-11-15
TW505635B (en) 2002-10-11
DE69830157T2 (de) 2006-05-11
WO1998042675A1 (en) 1998-10-01
PL335885A1 (en) 2000-05-22
DK0971898T3 (da) 2005-09-05
IS8717A (is) 2008-03-03
IS2346B (is) 2008-03-15
JP2008019272A (ja) 2008-01-31
KR20010005621A (ko) 2001-01-15
KR100578443B1 (ko) 2006-05-11
EP0971898B1 (de) 2005-05-11
ID22901A (id) 1999-12-16
BR9808422A (pt) 2000-05-23
EP1380573B1 (de) 2009-05-06
JP2002517168A (ja) 2002-06-11
EA002224B1 (ru) 2002-02-28
YU48399A (sh) 2002-06-19
HRP980157B1 (en) 2004-10-31
DK0975599T3 (da) 2004-03-15
KR20050103984A (ko) 2005-11-01
HUP0001556A3 (en) 2002-01-28
AU745382B2 (en) 2002-03-21
KR100554601B1 (ko) 2006-03-03

Similar Documents

Publication Publication Date Title
ATE430734T1 (de) Isochinoline und deren herstellung
DE69821951D1 (de) Bernsteinsäure herstellung und reinigung
EP0790826A4 (de) Dyhydropyrimidine und deren verwendungen
DE69929456D1 (de) Nahfeldabtastkopf und herstellungsverfahren
DE69825434D1 (de) Schirmgehäuse und dessen herstellungsverfahren
DE69634852D1 (de) Modulaire stuhlkonstruktion und zusammenbauverfahren
DE69808499D1 (de) Widerstand und herstellungsverfahren
DE69838849D1 (de) Mehrchipmodulstruktur und seine herstellung
DE69937352D1 (de) Maiszellulosesynthasen und deren verwendungen
DE69637728D1 (de) Halbleiterbauteil und Herstellung desselben
ATE284392T1 (de) Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung
DE69506946D1 (de) Microporöse Keramiken und deren Herstellung
DE69814431D1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
DE69503139D1 (de) Schuhwerk und dessen herstellung
DE69931405D1 (de) Haftverschlüsse und deren Herstellung
DE69516198D1 (de) Textil-Strukturen und ihre Herstellung
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
DE69831750D1 (de) Biozide und biozide tücher
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
DE69827144D1 (de) Neue blockpolymere und deren herstellung
DE69821551D1 (de) Folientastatur und deren Herstellungsmethoden
DE69820182D1 (de) Bodenbelag und zugehöriges Herstellungsverfahren
DE69532131D1 (de) Heizvorrichtung und ihre herstellung
DE69510496D1 (de) Microporösen Kermamiken und deren Herstellung
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties